South Africa has its own national registry, South African National Clinical Trial Registry (SANCTR). SANCTR is not a World Health Organization (WHO) recognized primary registry. It has a provision for registering studies conducted in South Africa. All new clinical trials from 1st December 2005 or the trials that started recruiting as of 1st July 2005 must be registered on SANCTR. Additionally, protocol registration and results posting can be done voluntarily on Pan African Clinical Trial Registry, which is a WHO recognized primary registry.

Registries at a Glance
Registry	PHUSE Categorization	Information to be Entered By	Route of Data in Registry	Study Type	Language
SANCTR	Mandatory National Database (includes Ethics Requirement)	Investigator, Sponsor	Through a dedicated registration platform (process independent from clinical trial application)	Interventional (Phase 1-4); Observational	English

Registry Updates

• February 2022: Pan African Clinical Trials Registry and South African Clinical Trials Registry Update - The Pan African Clinical Trials Registry (PACTR) and South African Clinical Trials Registry (SANCTR) have made an important announcement on a few enhancements to improve the functionality of the registry. New filters have been included for easy tracking of the “submitted” or “in process” trials. Researchers should see their trials under “My trials” tab for … Continue reading "February 2022: Pan African Clinical Trials Registry and South African Clinical Trials Registry Update"
• June 2020: South Africa Regulatory Update - Introducing a New Online Platform for African Trials The African Academy of Sciences (AAS) in June 2020, launched a first iteration of the Clinical Trials Community (CTC) online platform with features that will increase the visibility of African clinical trial sites and investigators with potential to participate in COVID-19 clinical trials. This platform will promote … Continue reading "June 2020: South Africa Regulatory Update"

References